[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Gastrointestinal Cancer Drug Market Report 2017

January 2018 | 101 pages | ID: A2399258F01EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Gastrointestinal Cancer Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Gastrointestinal Cancer Drug for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Gastrointestinal Cancer Drug market competition by top manufacturers/players, with Gastrointestinal Cancer Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Celgene Corporation
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Sanofi
  • Novartis AG.
  • Bristol-Myers Squibb Company
  • Amgen Limited & Amgen Ireland Limited
  • Johnson & Johnson Private Limited
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • By Therapy
    • Immunotherapy
    • Chemotherapy
    • Targeted Therapy
    • Radiation Therapy
    • Hormone Therapy
    • Adjuvant Chemotherapy
  • By Route of Administration
    • Oral
    • Injectable Therapy
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Radiology
  • Oncology
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Gastrointestinal Cancer Drug Market Report 2017

1 GASTROINTESTINAL CANCER DRUG OVERVIEW

1.1 Product Overview and Scope of Gastrointestinal Cancer Drug
1.2 Classification of Gastrointestinal Cancer Drug by Product Category
  1.2.1 Asia-Pacific Gastrointestinal Cancer Drug Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Gastrointestinal Cancer Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Immunotherapy
  1.2.4 Chemotherapy
  1.2.5 Targeted Therapy
  1.2.6 Radiation Therapy
  1.2.7 Hormone Therapy
  1.2.8 Adjuvant Chemotherapy
1.3 Asia-Pacific Gastrointestinal Cancer Drug Market by Application/End Users
  1.3.1 Asia-Pacific Gastrointestinal Cancer Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Radiology
  1.3.3 Oncology
1.4 Asia-Pacific Gastrointestinal Cancer Drug Market by Region
  1.4.1 Asia-Pacific Gastrointestinal Cancer Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Gastrointestinal Cancer Drug (2012-2022)
  1.5.1 Asia-Pacific Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC GASTROINTESTINAL CANCER DRUG COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Gastrointestinal Cancer Drug Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Gastrointestinal Cancer Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Gastrointestinal Cancer Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Gastrointestinal Cancer Drug (Volume and Value) by Type
  2.2.1 Asia-Pacific Gastrointestinal Cancer Drug Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Gastrointestinal Cancer Drug Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Gastrointestinal Cancer Drug (Volume) by Application
2.4 Asia-Pacific Gastrointestinal Cancer Drug (Volume and Value) by Region
  2.4.1 Asia-Pacific Gastrointestinal Cancer Drug Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Gastrointestinal Cancer Drug Revenue and Market Share by Region (2012-2017)

3 CHINA GASTROINTESTINAL CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 China Gastrointestinal Cancer Drug Sales and Value (2012-2017)
  3.1.1 China Gastrointestinal Cancer Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2017)
  3.1.3 China Gastrointestinal Cancer Drug Sales Price Trend (2012-2017)
3.2 China Gastrointestinal Cancer Drug Sales Volume and Market Share by Type
3.3 China Gastrointestinal Cancer Drug Sales Volume and Market Share by Application

4 JAPAN GASTROINTESTINAL CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Gastrointestinal Cancer Drug Sales and Value (2012-2017)
  4.1.1 Japan Gastrointestinal Cancer Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Gastrointestinal Cancer Drug Sales Price Trend (2012-2017)
4.2 Japan Gastrointestinal Cancer Drug Sales Volume and Market Share by Type
4.3 Japan Gastrointestinal Cancer Drug Sales Volume and Market Share by Application

5 SOUTH KOREA GASTROINTESTINAL CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Gastrointestinal Cancer Drug Sales and Value (2012-2017)
  5.1.1 South Korea Gastrointestinal Cancer Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Gastrointestinal Cancer Drug Sales Price Trend (2012-2017)
5.2 South Korea Gastrointestinal Cancer Drug Sales Volume and Market Share by Type
5.3 South Korea Gastrointestinal Cancer Drug Sales Volume and Market Share by Application

6 TAIWAN GASTROINTESTINAL CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Gastrointestinal Cancer Drug Sales and Value (2012-2017)
  6.1.1 Taiwan Gastrointestinal Cancer Drug Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Gastrointestinal Cancer Drug Sales Price Trend (2012-2017)
6.2 Taiwan Gastrointestinal Cancer Drug Sales Volume and Market Share by Type
6.3 Taiwan Gastrointestinal Cancer Drug Sales Volume and Market Share by Application

7 INDIA GASTROINTESTINAL CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 India Gastrointestinal Cancer Drug Sales and Value (2012-2017)
  7.1.1 India Gastrointestinal Cancer Drug Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2017)
  7.1.3 India Gastrointestinal Cancer Drug Sales Price Trend (2012-2017)
7.2 India Gastrointestinal Cancer Drug Sales Volume and Market Share by Type
7.3 India Gastrointestinal Cancer Drug Sales Volume and Market Share by Application

8 SOUTHEAST ASIA GASTROINTESTINAL CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Gastrointestinal Cancer Drug Sales and Value (2012-2017)
  8.1.1 Southeast Asia Gastrointestinal Cancer Drug Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Gastrointestinal Cancer Drug Sales Price Trend (2012-2017)
8.2 Southeast Asia Gastrointestinal Cancer Drug Sales Volume and Market Share by Type
8.3 Southeast Asia Gastrointestinal Cancer Drug Sales Volume and Market Share by Application

9 AUSTRALIA GASTROINTESTINAL CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Gastrointestinal Cancer Drug Sales and Value (2012-2017)
  9.1.1 Australia Gastrointestinal Cancer Drug Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Gastrointestinal Cancer Drug Sales Price Trend (2012-2017)
9.2 Australia Gastrointestinal Cancer Drug Sales Volume and Market Share by Type
9.3 Australia Gastrointestinal Cancer Drug Sales Volume and Market Share by Application

10 ASIA-PACIFIC GASTROINTESTINAL CANCER DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Celgene Corporation
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Celgene Corporation Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 F. Hoffmann-La Roche Ltd.
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Eli Lilly and Company
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Eli Lilly and Company Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 GlaxoSmithKline plc.
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Pfizer Inc.
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Pfizer Inc. Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Sanofi
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Sanofi Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Novartis AG.
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Novartis AG. Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Bristol-Myers Squibb Company
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Amgen Limited & Amgen Ireland Limited
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Johnson & Johnson Private Limited
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview

11 GASTROINTESTINAL CANCER DRUG MANUFACTURING COST ANALYSIS

11.1 Gastrointestinal Cancer Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Gastrointestinal Cancer Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Gastrointestinal Cancer Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Gastrointestinal Cancer Drug Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC GASTROINTESTINAL CANCER DRUG MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Gastrointestinal Cancer Drug Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Gastrointestinal Cancer Drug Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Gastrointestinal Cancer Drug Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Gastrointestinal Cancer Drug Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Gastrointestinal Cancer Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Gastrointestinal Cancer Drug Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Gastrointestinal Cancer Drug Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Gastrointestinal Cancer Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Gastrointestinal Cancer Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Gastrointestinal Cancer Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Gastrointestinal Cancer Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Gastrointestinal Cancer Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Gastrointestinal Cancer Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Gastrointestinal Cancer Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Gastrointestinal Cancer Drug Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Gastrointestinal Cancer Drug Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Gastrointestinal Cancer Drug Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Gastrointestinal Cancer Drug Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Gastrointestinal Cancer Drug Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Gastrointestinal Cancer Drug
Figure Asia-Pacific Gastrointestinal Cancer Drug Sales Volume (MT) by Type (2012-2022)
Figure Asia-Pacific Gastrointestinal Cancer Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Immunotherapy Product Picture
Figure Chemotherapy Product Picture
Figure Targeted Therapy Product Picture
Figure Radiation Therapy Product Picture
Figure Hormone Therapy Product Picture
Figure Adjuvant Chemotherapy Product Picture
Figure Asia-Pacific Gastrointestinal Cancer Drug Sales (MT) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Gastrointestinal Cancer Drug by Application in 2016
Figure Radiology Examples
Table Key Downstream Customer in Radiology
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Asia-Pacific Gastrointestinal Cancer Drug Market Size (Million USD) by Region (2012-2022)
Figure China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Gastrointestinal Cancer Drug Sales Volume (MT) and Growth Rate (2012-2022)
Figure Asia-Pacific Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Gastrointestinal Cancer Drug Market Major Players Product Sales Volume (MT)(2012-2017)
Table Asia-Pacific Gastrointestinal Cancer Drug Sales (MT) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Gastrointestinal Cancer Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Gastrointestinal Cancer Drug Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Gastrointestinal Cancer Drug Sales Share by Players/Suppliers
Figure Asia-Pacific Gastrointestinal Cancer Drug Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Gastrointestinal Cancer Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Gastrointestinal Cancer Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Gastrointestinal Cancer Drug Revenue Share by Players
Figure 2017 Asia-Pacific Gastrointestinal Cancer Drug Revenue Share by Players
Table Asia-Pacific Gastrointestinal Cancer Drug Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Gastrointestinal Cancer Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Gastrointestinal Cancer Drug by Type (2012-2017)
Figure Asia-Pacific Gastrointestinal Cancer Drug Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Gastrointestinal Cancer Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Gastrointestinal Cancer Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gastrointestinal Cancer Drug by Type (2012-2017)
Figure Asia-Pacific Gastrointestinal Cancer Drug Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Gastrointestinal Cancer Drug Sales Volume (MT) and Market Share by Region (2012-2017)
Table Asia-Pacific Gastrointestinal Cancer Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Gastrointestinal Cancer Drug by Region (2012-2017)
Figure Asia-Pacific Gastrointestinal Cancer Drug Sales Market Share by Region in 2016
Table Asia-Pacific Gastrointestinal Cancer Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Gastrointestinal Cancer Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Gastrointestinal Cancer Drug by Region (2012-2017)
Figure Asia-Pacific Gastrointestinal Cancer Drug Revenue Market Share by Region in 2016
Table Asia-Pacific Gastrointestinal Cancer Drug Sales Volume (MT) and Market Share by Application (2012-2017)
Table Asia-Pacific Gastrointestinal Cancer Drug Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Gastrointestinal Cancer Drug Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Gastrointestinal Cancer Drug Sales Market Share by Application (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Price (USD/Kg) Trend (2012-2017)
Table China Gastrointestinal Cancer Drug Sales Volume (MT) by Type (2012-2017)
Table China Gastrointestinal Cancer Drug Sales Volume Market Share by Type (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Volume Market Share by Type in 2016
Table China Gastrointestinal Cancer Drug Sales Volume (MT) by Applications (2012-2017)
Table China Gastrointestinal Cancer Drug Sales Volume Market Share by Application (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Volume Market Share by Application in 2016
Figure Japan Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure Japan Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Gastrointestinal Cancer Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Japan Gastrointestinal Cancer Drug Sales Volume (MT) by Type (2012-2017)
Table Japan Gastrointestinal Cancer Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Gastrointestinal Cancer Drug Sales Volume Market Share by Type in 2016
Table Japan Gastrointestinal Cancer Drug Sales Volume (MT) by Applications (2012-2017)
Table Japan Gastrointestinal Cancer Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Gastrointestinal Cancer Drug Sales Volume Market Share by Application in 2016
Figure South Korea Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure South Korea Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Gastrointestinal Cancer Drug Sales Price (USD/Kg) Trend (2012-2017)
Table South Korea Gastrointestinal Cancer Drug Sales Volume (MT) by Type (2012-2017)
Table South Korea Gastrointestinal Cancer Drug Sales Volume Market Share by Type (2012-2017)
Figure South Korea Gastrointestinal Cancer Drug Sales Volume Market Share by Type in 2016
Table South Korea Gastrointestinal Cancer Drug Sales Volume (MT) by Applications (2012-2017)
Table South Korea Gastrointestinal Cancer Drug Sales Volume Market Share by Application (2012-2017)
Figure South Korea Gastrointestinal Cancer Drug Sales Volume Market Share by Application in 2016
Figure Taiwan Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure Taiwan Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Gastrointestinal Cancer Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Taiwan Gastrointestinal Cancer Drug Sales Volume (MT) by Type (2012-2017)
Table Taiwan Gastrointestinal Cancer Drug Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Gastrointestinal Cancer Drug Sales Volume Market Share by Type in 2016
Table Taiwan Gastrointestinal Cancer Drug Sales Volume (MT) by Applications (2012-2017)
Table Taiwan Gastrointestinal Cancer Drug Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Gastrointestinal Cancer Drug Sales Volume Market Share by Application in 2016
Figure India Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure India Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Gastrointestinal Cancer Drug Sales Price (USD/Kg) Trend (2012-2017)
Table India Gastrointestinal Cancer Drug Sales Volume (MT) by Type (2012-2017)
Table India Gastrointestinal Cancer Drug Sales Volume Market Share by Type (2012-2017)
Figure India Gastrointestinal Cancer Drug Sales Volume Market Share by Type in 2016
Table India Gastrointestinal Cancer Drug Sales Volume (MT) by Application (2012-2017)
Table India Gastrointestinal Cancer Drug Sales Volume Market Share by Application (2012-2017)
Figure India Gastrointestinal Cancer Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure Southeast Asia Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Gastrointestinal Cancer Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Southeast Asia Gastrointestinal Cancer Drug Sales Volume (MT) by Type (2012-2017)
Table Southeast Asia Gastrointestinal Cancer Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Gastrointestinal Cancer Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Gastrointestinal Cancer Drug Sales Volume (MT) by Applications (2012-2017)
Table Southeast Asia Gastrointestinal Cancer Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Gastrointestinal Cancer Drug Sales Volume Market Share by Application in 2016
Figure Australia Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure Australia Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Gastrointestinal Cancer Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Australia Gastrointestinal Cancer Drug Sales Volume (MT) by Type (2012-2017)
Table Australia Gastrointestinal Cancer Drug Sales Volume Market Share by Type (2012-2017)
Figure Australia Gastrointestinal Cancer Drug Sales Volume Market Share by Type in 2016
Table Australia Gastrointestinal Cancer Drug Sales Volume (MT) by Applications (2012-2017)
Table Australia Gastrointestinal Cancer Drug Sales Volume Market Share by Application (2012-2017)
Figure Australia Gastrointestinal Cancer Drug Sales Volume Market Share by Application in 2016
Table Celgene Corporation Gastrointestinal Cancer Drug Basic Information List
Table Celgene Corporation Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Basic Information List
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Eli Lilly and Company Gastrointestinal Cancer Drug Basic Information List
Table Eli Lilly and Company Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table GlaxoSmithKline plc. Gastrointestinal Cancer Drug Basic Information List
Table GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer Inc. Gastrointestinal Cancer Drug Basic Information List
Table Pfizer Inc. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Inc. Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure Pfizer Inc. Gastrointestinal Cancer Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Inc. Gastrointestinal Cancer Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi Gastrointestinal Cancer Drug Basic Information List
Table Sanofi Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure Sanofi Gastrointestinal Cancer Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi Gastrointestinal Cancer Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Novartis AG. Gastrointestinal Cancer Drug Basic Information List
Table Novartis AG. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis AG. Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure Novartis AG. Gastrointestinal Cancer Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis AG. Gastrointestinal Cancer Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Basic Information List
Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Basic Information List
Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Basic Information List
Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Kg) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal Cancer Drug
Figure Manufacturing Process Analysis of Gastrointestinal Cancer Drug
Figure Gastrointestinal Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Gastrointestinal Cancer Drug Major Manufacturers in 2016
Table Major Buyers of Gastrointestinal Cancer Drug
Table Distributors/Traders List
Figure Asia-Pacific Gastrointestinal Cancer Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Gastrointestinal Cancer Drug Price (USD/Kg) and Trend Forecast (2017-2022)
Table Asia-Pacific Gastrointestinal Cancer Drug Sales Volume (MT) Forecast by Region (2017-2022)
Figure Asia-Pacific Gastrointestinal Cancer Drug Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Gastrointestinal Cancer Drug Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Gastrointestinal Cancer Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Gastrointestinal Cancer Drug Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Gastrointestinal Cancer Drug Revenue Market Share Forecast by Region in 2022
Figure China Gastrointestinal Cancer Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Gastrointestinal Cancer Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Gastrointestinal Cancer Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure South Korea Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Gastrointestinal Cancer Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Taiwan Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Gastrointestinal Cancer Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure India Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Gastrointestinal Cancer Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Gastrointestinal Cancer Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Australia Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Gastrointestinal Cancer Drug Sales (MT) Forecast by Type (2017-2022)
Figure Asia-Pacific Gastrointestinal Cancer Drug Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Gastrointestinal Cancer Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Gastrointestinal Cancer Drug Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Gastrointestinal Cancer Drug Price (USD/Kg) Forecast by Type (2017-2022)
Table Asia-Pacific Gastrointestinal Cancer Drug Sales (MT) Forecast by Application (2017-2022)
Figure Asia-Pacific Gastrointestinal Cancer Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories